Open AccessPathological Assessment of Gastrointestinal Biopsies from Patients with Idelalisib-Associated Diarrhea and Colitis
Author(s) -
Cecilia C.S. Yeung,
David M. Hockenbery,
Maria Westerhoff,
Steven Coutré,
Ruth Hall Sedlak,
Ronald L. Dubowy,
Veerendra Munugalavadla,
Kerry Taylor,
Francesc Bosch
Publication year - 2018
Publication title -
future oncology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.857
H-Index - 72
eISSN - 1744-8301
pISSN - 1479-6694
DOI - 10.2217/fon-2017-0528
Subject(s) - medicine , gastroenterology , pathological , diarrhea , colitis , idelalisib , ibrutinib , chronic lymphocytic leukemia , leukemia
Idelalisib (IDELA) treatment is associated with diarrhea/colitis (incidence of ∼15% grade ≥3). We performed a retrospective analysis of gastrointestinal biopsies from 29 patients treated with IDELA across nine clinical trials.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom